NCT06152523 2026-04-06
MONAMI
Assistance Publique - Hôpitaux de Paris
Phase 2 Withdrawn
Clinical Trials
24 trialsNCT07222358 2026-04-06
Multi-component Remote Assessment in Adult Survivors Using a Connected Technology Platform for Healthcare Delivery
St. Jude Children's Research Hospital
Withdrawn
NCT07484282 2026-04-03
Quality of Care for Adolescent and Young Adult (AYA) Patients Living With Serious or Advanced Cancer
National Institutes of Health Clinical Center (CC)
Withdrawn
NCT07313891 2026-03-17
BOOST
Relmada Therapeutics, Inc.
Phase 3 Withdrawn
NCT07342517 2026-03-17
RESCUE
Relmada Therapeutics, Inc.
Phase 3 Withdrawn
NCT06240377 2026-03-09
Effectiveness of NMP and TDCS vs Pharmacological Treatment in Cancer Patients With Lower Limb Pain
Universidad Europea de Canarias
Phase NA Withdrawn
NCT06240390 2026-03-09
Effectiveness of Percutaneous Neuromodulation vs Pharmacological Treatment in Cancer Patients With Anterior Knee Pain
Universidad Europea de Canarias
Phase NA Withdrawn
NCT04482933 2026-02-10
HSV G207 With a Single Radiation Dose in Children With Recurrent High-Grade Glioma
Pediatric Brain Tumor Consortium
Phase 2 Withdrawn
NCT06922825 2026-01-21
Pilot Study Evaluating Tumor Microenvironment Interaction in Solid Tumor Patients
Vanderbilt-Ingram Cancer Center
Phase EARLY_PHASE1 Withdrawn
NCT03135743 2026-01-16
LYMPHOSYNCHRO
Centre Hospitalier Universitaire, Amiens
Withdrawn
NCT07071909 2026-01-06
Immune Reconstitution Monitoring and Pneumococcal Vaccination in Patients Treated With CAR-T Cells
UNC Lineberger Comprehensive Cancer Center
Phase 1/2 Withdrawn
NCT07293520 2025-12-26
Improving Consent Experiences in Clinical Trials
Washington University School of Medicine
Phase NA Withdrawn
NCT04020029 2025-12-19
Leveraging Mindsets to Improve Health and Wellbeing in Patients With Cancer
Stanford University
Phase NA Withdrawn
NCT06116578 2025-12-01
NeoSarc
Gustave Roussy, Cancer Campus, Grand Paris
Phase 2 Withdrawn
NCT04036045 2025-10-06
Approaches to Identify Early Biomarkers and Pathogenesis of Anthracycline Cardiotoxicity
Connecticut Children's Medical Center
Withdrawn
NCT06690281 2025-09-11
A Phase II Study of Adjuvant Immunotherapy Targeting KRAS G12D, KRAS G12V, or TP53 R175H for Participants With Advanced Gastrointestinal Malignancies
National Institutes of Health Clinical Center (CC)
Phase 2 Withdrawn
NCT05052632 2025-08-13
Evaluating a New Gonadotoxic Risk Stratification System
University of Colorado, Denver
Withdrawn
NCT05000905 2025-08-06
Improving Cognition and Behavior in Pediatric Cancer Survivors Using a Novel Mindful Attention Training
University of California, San Francisco
Phase NA Withdrawn
NCT05917990 2025-07-28
Dyadic Text-Messaging Micro-Intervention
Duke University
Phase NA Withdrawn
NCT06161558 2025-07-16
Erlotinib in Combination With Select Tyrosine Kinase Inhibitors in Adult Patients With Advanced Solid Tumors
National Institutes of Health Clinical Center (CC)
Phase 1 Withdrawn
NCT05257707 2025-07-09
MOCA
Centre Hospitalier Universitaire de Besancon
Phase NA Withdrawn
NCT02077621 2025-06-04
Study of PG2 Injection for Improving Fatigue in Patients After Palliative Abdominal Surgery for Cancer
PhytoHealth Corporation
Phase 2 Withdrawn
NCT06390657 2025-05-11
S-C-PATHY
EBG MedAustron GmbH
Withdrawn
NCT02591433 2025-05-01
JeffQuit Group Therapy Program for Smoking Cessation in Patients With a History of Cancer
Thomas Jefferson University
Phase NA Withdrawn